Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Cellectar Biosc
(NQ:
CLRB
)
2.110
+0.020 (+0.96%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cellectar Biosc
< Previous
1
2
3
Next >
Why Energy Stocks Traded Higher; Here Are 61 Biggest Movers From Yesterday
July 26, 2022
Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 150.4% to close at $1.59 on Monday after declining 8% on Friday.
Via
Benzinga
Why Is Infrastructure and Energy Alternatives Higher By Around 29%? 37 Stocks Moving In Monday's Mid-Day Session
July 25, 2022
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 104% to $1.3263 after the company announced that primary endpoint was met in study for its treatment of allergic rhinitis.
Via
Benzinga
Daily Biotech Pulse: VistaGen's Anxiety Study Fails, Silverback To Merge With Firm Developing EpiPen Alternative, Setback For Liminal's Lead Asset
July 22, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
July 21, 2022
Gainers Hanger (NYSE:HNGR) stock moved upwards by 27.1% to $18.75 during Thursday's after-market session. The company's market cap stands at $731.7 million.
Via
Benzinga
Why Is United Airlines Down By Over 6%? Here Are 25 Stocks Moving In Thursday's Pre-Market Session
July 21, 2022
Gainers Tuesday Morning Corporation (NASDAQ: TUEM) rose 72.1% to $0.3420 in pre-market trading after dipping 30% on Wednesday. Tuesday Morning recently announced partnership with Intalytics for...
Via
Benzinga
Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday
July 21, 2022
Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 20, 2022
Via
Benzinga
Recap: Cellectar Biosciences Q1 Earnings
May 10, 2022
Cellectar Biosciences (NASDAQ:CLRB) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Cellectar Biosciences...
Via
Benzinga
51 Biggest Movers From Thursday
April 18, 2022
Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 69.4% to close at $2.44 on Thursday. Ally Bridge Group recently reported a purchase of 21.176 million shares of...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 14, 2022
Gainers
Via
Benzinga
Here's Why Cellectar Biosciences Shares Are Rising
March 21, 2022
Cellectar Biosciences Inc (NASDAQ: CLRB) shares are trading higher by 12.1% at $0.61 after the company reported better-than-expected fourth-quarter EPS results. Cellectar Biosciences beat estimated...
Via
Benzinga
Recap: Cellectar Biosciences Q4 Earnings
March 21, 2022
Cellectar Biosciences (NASDAQ:CLRB) reported its Q4 earnings results on Monday, March 21, 2022 at 08:30 AM. Here's what investors need to know about the announcement....
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 07, 2022
Gainers Agile Therapeutics (NASDAQ:AGRX) ...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 28, 2022
Gainers Enveric Biosciences (NASDAQ:ENVB)...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 07, 2021
Gainers PLx Pharma (NASDAQ:PLXP) stock in...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
October 28, 2021
Gainers Bellerophon Therapeutics (NASDAQ:
Via
Benzinga
Cellectar Bio's Iopofosine Data Shows Favorable Safety Profile In Head & Neck Cancer
September 22, 2021
Cellectar Biosciences Inc (NASDAQ: CLRB) has completed part A portion of a safety and tolerability study of iopofosine I-131 (iopofosine) in combination with...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 09, 2021
Gainers Soligenix (NASDAQ:SNGX) stock increased by 22.85% to $1.29 during Thursday's pre-market session. The company's market cap stands at $51.7 million. Cardiff...
Via
Benzinga
4 Penny Stocks Insiders Are Buying
September 08, 2021
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 07, 2021
Gainers Cellectar Biosciences (NASDAQ:CLRB
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
August 26, 2021
Gainers MorphoSys (NASDAQ:MOR) stock move...
Via
Benzinga
Cellectar Receives $2M NIH Grant For Rare Lymphoma Study
August 18, 2021
Cellectar Biosciences Inc (NASDAQ: CLRB) has received a peer-reviewed National Institutes of Health (NIH) Phase II Small Business Innovation Research (SBIR) grant of...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 10, 2021
Before 10 a.m. ET on Tuesday, 60 companies set new 52-week lows. Key Facts: PACCAR (NASDAQ:PCAR) was the biggest company by market cap to set a new 52-week low....
Via
Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
August 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
August 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...
Via
Benzinga
Exposures
Product Safety
Cellectar, LegoChemBio Team Up To Develop Phospholipid Drug Conjugates For Solid Tumors
July 12, 2021
Cellectar Biosciences Inc (NASDAQ: CLRB) has collaborated with LegoChemBio to develop and commercialize phospholipid drug conjugates (PDCs). Under the agreement,...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
July 02, 2021
Gainers Alector (NASDAQ:ALEC) shares moved upwards by 52.47% to $34.17 during Friday's regular session. Alector's stock is trading at a volume of 26.9 million...
Via
Benzinga
Cellectar Bio Stock Drops After ASCO Presentation on White Blood Cell Cancer Therapy
June 04, 2021
Cellectar Biosciences Inc (NASDAQ: CLRB) announced updated data at the American Society of Clinical Oncology (ASCO) Annual Meeting from Phase 2 CLOVER-1 study of...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.